GOLPH3 is a novel marker of poor prognosis and a potential therapeutic target in human renal cell carcinoma.
Xue Y, Wu G, Liao Y, Xiao G, Ma X, Zou X, Zhang G, Xiao R, Wang X, Liu Q, Long D, Yang J, Xu H, Liu F, Liu M, Xie K, Huang R.
Xue Y, et al. Among authors: zhang g.
Br J Cancer. 2014 Apr 29;110(9):2250-60. doi: 10.1038/bjc.2014.124. Epub 2014 Mar 4.
Br J Cancer. 2014.
PMID: 24595000
Free PMC article.